Volitionrx Ltd (New York Stock Exchange Arca:VNRX)
| Market Cap | 1.89M-98.3% |
| Revenue (ttm) | 2.46M+86.3% |
| Net Income | -25.64M-9.9% |
| EPS | -3.87+22.5% |
| Shares Out | 12.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,345,849 |
| Open | 0.24 |
| Previous Close | 0.24 |
| Day's Range | 0.22 - 0.24 |
| 52-Week Range | 0.22 - 12.80 |
| Beta | 1.17 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About VNRX
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
$VNRX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in VNRX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by VNRX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
VNRX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New VNRX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to VNRX from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in VNRX
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $21.99K |
| STSBiShares Factors US Small Blend Style ETF | $615.59 |
Estimated from each fund’s disclosed top holdings × AUM
VNRX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from VNRX’s recent data — informational, not investment advice